Genesis Innovation Group Unveils Capitan Orthopedics to Innovate Shoulder Injury Solutions

Genesis Innovation Group Unveils New Subsidiary: Capitan Orthopedics, Inc.

On January 20, 2026, Genesis Innovation Group (GIG), a prominent medical device development firm based in the United States, proudly announced the formation of its newest subsidiary, Capitan Orthopedics, Inc. This strategic move is set to revolutionize treatment options for patients battling rotator cuff injuries, which affect millions each year.

At the forefront of Capitan Orthopedics' initiative is its innovative product, the SupraSpacerTM, a minimally invasive implant designed specifically for patients suffering from irreparable rotator cuff tears. The SupraSpacerTM aims to provide a long-term biomechanical solution, helping restore joint alignment and ensuring a pain-free range of motion, all while maintaining future surgical options.

According to Chance Leonard, CEO of both Genesis Innovation Group and Capitan Orthopedics, the need for better solutions is glaringly apparent. "Today, over 2 million individuals are diagnosed with a rotator cuff injury annually, and more than 700,000 undergo surgeries to repair these tears. Unfortunately, there exists a significant gap in care for those with irreparable cuff tears, leading to ongoing patient suffering due to limited treatment options," he stated.

The development of the SupraSpacerTM represents a significant milestone in orthopedic treatment. Leonard emphasized that the implant has been crafted by a team of experienced design surgeons and engineers to create a procedure that is not only effective but also simple and reproducible. This advancement is particularly crucial since many traditional treatments, such as physical therapy, injections, and tendon transfers, have often fallen short for patients with irreparable tears, leaving them frustrated with painful and limited shoulder function.

Dr. R. Sean Churchill, MD, MBA, the lead surgeon designer, expressed his enthusiasm about the project, stating, "Capitan Orthopedics is tackling one of the most common and vexing challenges faced by orthopedic surgeons today—painful, irreparable rotator cuff tears in patients aged 25 to 60. The SupraSpacerTM implant is specifically designed to help mitigate issues related to shoulder arthritis while enhancing joint movement by keeping the humeral head centered within the joint. This innovation will allow patients to regain full, impingement-free mobility."

Leonard further noted that irreparable rotator cuff tears represent a considerable portion of the patient population, and emphasizing a minimally invasive, bone-sparing approach allows surgeons to provide a lasting solution that enhances patient care. The commitment to bringing the SupraSpacerTM to market quickly showcases GIG's dedication to improving patient outcomes across the board.

Genesis Innovation Group is recognized as a leader in medical device development and commercialization within the U.S. They partner with inventors, entrepreneurs, and early-stage medical device companies to create technologies aimed at dramatically enhancing patient care. With a wealth of expertise, the Genesis team boasts 377 years of combined engineering experience, 227 patents, and 154 510(k) clearances alongside facilitating 13 successful exits.

For more information about Genesis Innovation Group and its new subsidiary, Capitan Orthopedics, visit Genesis Innovation Group and Capitan Orthopedics. Promising advancements in orthopedic care and enhanced patient outcomes are on the horizon, with Capitan Orthopedics leading the way in innovation.